Gencor Pacific, Inc., Anaheim, CA, has announced that its Caralluma fimbriata extract, branded Slimaluma, has been awarded patents in South Africa and in India.

Gencor Pacific, Inc., Anaheim, CA, has announced that its Caralluma fimbriata extract, branded Slimaluma, has been awarded patents in South Africa and in India. The South African patent number is 2005/9780 and the Indian patent number is 210052. Slimaluma is the original Caralluma fimbriata extract supported by human clinical studies and toxicity studies validating its efficacy and safety. Slimaluma is also protected by U.S. Patent No. 7,060,308. A few more patent applications are pending in the U.S., Canada and in various international markets, covering product, processes and uses of the product.